Several studies have demonstrated that the presence of epidermal growth factor receptor (EGFR) in bladder cancer is associated with high tumour stage and grade, and is a strong independent predictor of tumour progression and poor long-term survival (Lipponen and Eskelinen, 1994; Mellon et al, 1995). This evidence concerns the gene EGFR and neoplasm.